List of insiders holdings for IONIS PHARMACEUTICALS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
LILLY ELI & CO
10% Owner
2006-02-06 16:40:312,500,000
0
2,500,000Form 13G
CROOKE STANLEY T
Exec Chairman of the Board
2021-01-28 19:22:032021
497,502
499,523Form 4
BERTHELSEN SPENCER R
Director
2022-07-19 19:19:37145,782
70
145,852Form 4
Monia Brett P
Chief Executive Officer
2023-02-07 17:36:55145,305
0
145,305Form 4
WENDER JOSEPH H
Director
2022-07-19 19:21:5416,885
104,969
121,854Form 4
PARSHALL B LYNNE
Director
2022-07-19 19:21:35102,363
0
102,363Form 4
JONAS JEFFREY M
Executive Vice President
2008-01-04 21:27:4678,936
0
78,936Form 4
MUTO FREDERICK T
Director
2022-07-19 19:21:2376,482
1500
77,982Form 4
HOUGEN ELIZABETH L
EVP Finance & CFO
2023-02-07 17:36:4375,496
0
75,496Form 4
Geary Richard S
EVP Chief Development Officer
2023-02-07 17:36:3572,385
0
72,385Form 4
BENNETT C FRANK
EVP Chief Scientific Officer
2023-02-07 17:36:0469,651
0
69,651Form 4
XANTHOPOULOS KLEANTHIS G
President of Regulus
2007-12-05 17:42:5560,000
0
60,000Form 4
LOSCALZO JOSEPH
Director
Director
2022-07-19 19:21:0850,857
0
50,857Form 4
HERMAN JOAN E
Director
2022-07-19 19:20:4649,772
0
49,772Form 4
Castleman Breaux
Director
2020-07-06 17:30:5344,291
0
44,291Form 4
Wedel Mark K
VP & Chief Medical Officer
2007-07-10 18:21:0442,410
0
42,410Form 4
O'NEIL PATRICK R.
EVP CLO & General Counsel
2023-02-07 17:37:0741,581
0
41,581Form 4
ECKER DAVID J
Vice President
2008-09-03 17:57:3712,640
28,713
41,353Form 4
Treble Michael J
Vice President Pres of Ibis
2008-08-13 18:49:1332,500
0
32,500Form 4
Boyce Sarah
Chief Business Officer
2018-01-17 21:23:5732,274
0
32,274Form 4
Swayze Eric
EVP Research
2023-02-07 17:37:4931,941
0
31,941Form 4
COLE DOUGLAS L
Vice President
2004-03-09 18:06:3831,616
0
31,616Form 4
Hayden Michael R
Director
2022-10-18 19:10:4430,219
0
30,219Form 4
LEVIN ARTHUR A
Vice President
2007-04-27 19:44:1825,377
0
25,377Form 4
Schneider Eugene
EVP Chf Clinical Develop Ofcr
2023-02-07 17:37:3024,946
0
24,946Form 4
Reikes Peter N
Director
2021-10-19 18:29:2624,886
0
24,886Form 4
KLEIN JOSEPH III
Director
2023-01-18 20:19:0916,791
6100
22,891Form 4
Cadoret-Manier Onaiza
EVP Chf GL Pdt Str & Oper Ofc
2023-02-07 17:36:2421,227
0
21,227Form 4
MCNEIL JOHN A
Vice President
2005-01-04 17:57:5918,158
0
18,158Form 4
LOWENSTAM PATRICIA
Vice President
2005-01-04 17:52:2218,158
0
18,158Form 4
DiMarchi Richard D
Director
2010-07-02 14:29:1115,000
0
15,000Form 4
LUNDSTEDT KAREN S
Vice President
2004-03-12 17:59:3214,407
0
14,407Form 4
Diaz Allene M.
Director
2022-07-19 19:20:1713,333
0
13,333Form 4
McDevitt Damien
Chief Business Officer
2019-07-17 17:39:1113,198
0
13,198Form 4
GABRIELI CHRISTOPHER
Director
2005-07-06 18:46:2510000
0
10000Form 4
SKALETSKY MARK B
Director
2004-07-02 17:18:5110000
0
10000Form 4
Baroldi Joseph
EVP Chief Business Officer
2023-01-19 20:19:053613
4813
8426Form 4
HOLMLUND JON T
Vice President
2004-02-11 18:47:091966
5593
7559Form 4/A
BROWN RICHARD K
Vice President
2006-03-09 18:32:025118
0
5118Form 4
REED JOHN C
Director
2012-09-06 21:39:454900
0
4900Form 4
STEIN ARON
Vice President
2004-07-02 17:25:542136
0
2136Form 4
DE HAAN HANS A
VP Drug Development
2004-05-05 16:07:370
0
0Form 4